Find a Clinical Trial
Is a clinical trial right for you? Search our database to find studies for which you may be eligible.
A Randomized Open-Label Phase III Study of XL092 + Atezolizumab vs Regorafenib in Subjects with Metastatic Colorectal Cancer
A Phase III, Open-Label, Randomized Study of Perioperative Dostarlimab Monotherapy versus Standard of Care in Participants with Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
A Phase II Study of Savolitinib in Subjects with MET Amplified Metastatic Colorectal Cancer
PREEMPT CRC: PREvention Employing a Multiomics Plasma-based Test for ColoRectal Cancer
A Randomized Phase II Study of Trastuzumab and Pertuzumab TP Compared to Cetuximab and Irinotecan CETIRI in Advanced/Metastatic Colorectal Cancer MCRC with HER-2 Amplification
Study Type: Treatment
Phase: II
NCTID: NCT03365882
Principal Investigator:
Anup Kasi
A Phase II, Randomized, Open-Label Study Evaluating the Safety and Efficacy of Magrolimab in Combination With Bevacizumab and FOLFIRI Versus Bevacizumab and FOLFIRI in Previously Treated Advanced Inoperable Metastatic Colorectal Cancer CRC
Study Type: Treatment
Phase: II
NCTID: NCT05330429
Principal Investigator:
Anup Kasi
Omega 3 Fatty Acids in Colorectal Cancer CRC Prevention in Patients with Lynch Syndrome COLYNE
Study Type: Prevention
Phase: Feasibility/Pilot
NCTID: NCT03831698
Principal Investigator:
Anwaar Saeed
Adaptive Intervention to Maximize Colorectal Screening in Safety Net Populations
Study Type: Prevention
Phase: N/A
NCTID: NCT03100461
Principal Investigator:
Keith Allen Greiner JR